Mounting evidence suggests that pregnant people have an elevated risk of severe COVID-
19-related complications compared with their non-pregnant counterparts, underscoring the …

Pregnant people have an elevated risk of severe COVID-19-related complications compared
to their non-pregnant counterparts, underscoring the need for safe and effective therapies. In …

Background: COVID-19 is a viral infectious disease leading to a spectrum of clinical
complications, especially cardiovascular. Evidence shows that this infection can potentially …

In the absence of effective countermeasures, human convalescent plasma has been widely
used to treat severe acute respiratory syndrome coronavirus 2 including among patients with …

Abstract Background Coronavirus disease 2019 (COVID–19) is currently one of the world's
most critical health issues so far. Given the importance of appropriate treatment in …

The devastating coronavirus disease 2019 (COVID‐19) global pandemic caused by severe
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) was declared by the World Health …

The treatment of COVID-19 is particularly critical in pregnant women, considering the
potential teratogenic effects of antiviral agents and the immune-depression related with …

Objective To ascertain the composite maternal and neonatal outcomes in pregnant
individuals with moderate, severe, or critical coronavirus disease 2019 (COVID-19) treated …

SARS-CoV-2 infects cells via binding to ACE2 and TMPRSS2, which allows the virus to fuse
with host cells. The viral RNA is detected in the placenta of SARS-CoV-2-infected pregnant …

Since December 2019, the coronavirus disease (COVID-19) pandemic has had a disastrous
impact worldwide. COVID-19 is caused by the SARS-CoV-2 virus and was declared a …